These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 10745653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza.
    Dreitlein WB, Maratos J, Brocavich J.
    Clin Ther; 2001 Mar; 23(3):327-55. PubMed ID: 11318072
    [Abstract] [Full Text] [Related]

  • 26. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW.
    Commun Dis Intell Q Rep; 2003 Mar; 27(4):542-7. PubMed ID: 15508516
    [Abstract] [Full Text] [Related]

  • 27. Updated treatment for influenza A and B.
    Montalto NJ, Gum KD, Ashley JV.
    Am Fam Physician; 2000 Dec 01; 62(11):2467-76. PubMed ID: 11130232
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Critical review of anti-influenza drugs].
    van Loon FP, Voordouw AC, Simonian S, Koopmans PP.
    Ned Tijdschr Geneeskd; 2000 Jan 22; 144(4):165-7. PubMed ID: 10668542
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Progress treating, preventing influenza.
    Stephenson J.
    JAMA; 1998 Nov 25; 280(20):1729-30. PubMed ID: 9842933
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Zanamivir, oseltamivir].
    Kashiwagi S.
    Nihon Rinsho; 2004 Dec 25; 62 Suppl 12():445-7. PubMed ID: 15658359
    [No Abstract] [Full Text] [Related]

  • 36. Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy.
    Altschuler EL, Bhatia A, Kast RE.
    Kidney Int; 2005 Dec 25; 68(6):2910-1. PubMed ID: 16316376
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Safety of neuraminidase inhibitors for influenza.
    Jones M, Del Mar C.
    Expert Opin Drug Saf; 2006 Sep 25; 5(5):603-8. PubMed ID: 16907649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.